About Nova Leah:
Connected medical devices represent a rapidly growing sector in healthcare. There are currently between 10 to 15 billion such devices in use globally, and the global connected medical device market will exceed $136.8 billion by 2021.
Nova Leah was founded in Dundalk, Ireland as a spinout from our CEO’s PhD at the Dundalk Institute of Technology.
Since then, we’ve been fortunate to see our company and brand grow. We’ve been recognized as industry experts that deliver solutions to critical business challenges, and our technology continues to be adopted by top medical device companies.
About Anita Finnegan:
Dr. Anita Finnegan is the Founder and CEO of Nova Leah, a world leader in the provision of cybersecurity risk management solutions for connected medical devices. She is an internationally recognized expert in the field of medical device cybersecurity risk management and is an active member of a number of International Standards Communities. Her PhD research focused on medical device cybersecurity through the use of security assurance cases. In addition to many peered reviewed journals and a number of book chapters, Anita authored, and was the international project leader for two technical reports (IEC/TR 80001-2-8 and IEC/TR 80001-2-9).
In 2016, Anita spun-out Nova Leah from the research work she conducted in The Regulated Software Research Centre at Dundalk Institute of Technology. Through her work with Nova Leah, Finnegan has won multiple awards for innovation, security and technological impact. Nova Leah was named Emerging Company of Year at the 2019 Technology Ireland Awards in association with Ibec, KTI Spinout Company of the Year 2019 and was runner-up by DIGITALEUROPE for the European 'Future Unicorn Award' in 2020.